In June 2025, the global Malic Acid market faced significant volatility due to supply chain disruptions, uneven demand, and rising freight costs. China led the downturn with weak domestic demand and oversupply, while the U.S. market rebounded on restocking and limited imports. Raw material price pressure and logistics challenges compounded pricing instability, prompting end-users across industries—particularly food, pharma, cosmetics, and biofuels—to adopt flexible procurement and inventory strategies amid growing uncertainty.
The global Malic Acid market entered June 2025 with heightened volatility, driven by shifting demand, supply disruptions, and rising logistics costs. China led the downturn with price drops due to weak domestic demand and aggressive discounting, while the U.S. market rebounded on restocking and limited...
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
